PLYMOUTH MEETING, PA — INOVIO (NASDAQ: INO) will release its second-quarter 2025 financial results after the market closes on Tuesday, August 12. The company will host a conference call and webcast at 4:30 p.m. ET to review its performance and provide a business update, including a live Q&A with analysts.
INOVIO develops and commercializes DNA medicines targeting HPV-related diseases, cancers, and infectious diseases, using proprietary technology designed to train the body to generate its own therapeutic responses. An archived replay of the webcast will be available for 90 days.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.
